Literature DB >> 16308094

Prognostic/predictive factors in breast cancer.

Shahla Masood1.   

Abstract

This can be an exciting time for pathologists and cytopathologists as we refine or knowledge of prognostic/predictive factors in breast cancer. We can become more visible in our role as consultants to the other physicians, and more engaged in our role as re-searchers. Recent advances in computer science, coupled with the availability of new biological markers, now provide unique opportunities for us to expand our diagnostic abilities and also predict the biologic behavior of a given tumor. Thus, we must become more familiar with emerging concepts and technologies in different disciplines.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16308094     DOI： 10.1016/j.cll.2005.08.012

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN： 0272-2712            Impact factor:   1.935


  16 in total

Review 1.  Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer.

Authors:  E Nilüfer Güler
Journal:  Eur J Breast Health       Date:  2017-10-01

2.  Responding to a Community's Concern: A Comparison of Breast Cancer Characteristics and Initial Treatment in Three Selected North Carolina Counties.

Authors:  Anissa I Vines; William R Carpenter; Ronald C Chen; Michele W Cherry; Debra G Long; Keith D Amos; Paul A Godley
Journal:  N C Med J       Date:  2017 Nov-Dec

3.  Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance.

Authors:  Pankaj Taneja; Dejan Maglic; Fumitake Kai; Sinan Zhu; Robert D Kendig; Elizabeth A Fry; Kazushi Inoue
Journal:  Clin Med Insights Oncol       Date:  2010-04-20

4.  Breast cancer subtypes and survival in chinese women with operable primary breast cancer.

Authors:  Zhao-Sheng Li; Lu Yao; Yi-Qiang Liu; Tao Ouyang; Jin-Feng Li; Tian-Feng Wang; Zhao-Qing Fan; Tie Fan; Ben-Yao Lin; Yun-Tao Xie
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

5.  Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer.

Authors:  D Maglic; S Zhu; E A Fry; P Taneja; F Kai; R D Kendig; T Sugiyama; L D Miller; M C Willingham; K Inoue
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

6.  RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway.

Authors:  Guanglei Chen; Lisha Sun; Jianjun Han; Sufang Shi; Yuna Dai; Weiguang Liu
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

Review 7.  Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.

Authors:  Josee-Lyne Ethier; Danielle Desautels; Arnoud Templeton; Prakesh S Shah; Eitan Amir
Journal:  Breast Cancer Res       Date:  2017-01-05       Impact factor: 6.466

8.  Neutrophil to lymphocyte ratio is a prognostic factor for disease free survival in patients with breast cancer underwent curative resection.

Authors:  Sheng-Kai Geng; Shao-Mei Fu; Yi-Peng Fu; Hong-Wei Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.

Authors:  Emman Shubbar; Anikó Kovács; Shahin Hajizadeh; Toshima Z Parris; Szilárd Nemes; Katrin Gunnarsdóttir; Zakaria Einbeigi; Per Karlsson; Khalil Helou
Journal:  BMC Cancer       Date:  2013-01-02       Impact factor: 4.430

10.  The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients.

Authors:  Weijuan Jia; Jiannan Wu; Haixia Jia; Yaping Yang; Xiaolan Zhang; Kai Chen; Fengxi Su
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.